Revenue (Q4 2024): $76,663; YoY growth: 206.65%; QoQ growth: 7,566.30%
Gross Profit: $3,763; Gross Margin: 4.91%
Operating Income: -$408,790; Operating Margin: -5.33%
EBITDA: -$375,993; EBITDA Margin: -4.90%
Net Income: -$408,784; Net Margin: -5.33%
EPS (diluted): -$0.0339; Weighted Avg Shares: 12,052,372
Cash Flow: Net cash from operating activities -$198,583; Net cash used in investing activities -$50,000; Net cash provided by financing activities $185,000; Net change in cash: -$63,583; Ending cash: $75,063
Balance Sheet Health: Total assets $986.0m; Total liabilities $741.2m; Total stockholders’ equity $244.8m; Cash & equivalents $75.1m; Current ratio 0.12; Quick ratio 0.12; Inventory 0; Net debt $1.8k; Retained earnings negative $3.872b (illustrative of cumulative losses)
Valuation & Efficiency: Price-to-book 291.95x; Price-to-sales 932.27x; Enterprise value multiple -190.09x; Asset turnover 0.0777; Gross margin below technology/software benchmarks; Operating cash flow yield negative; Free cash flow per share $0.0172 (per ratio table); Operating cash flow per share -$0.0165.